Long and short non-coding RNAs as regulators of hematopoietic differentiation

International Journal of Molecular Sciences

Volumn 14, Issue 7, 2013, Pages 14744-14770

  Morceau, Franck ^a   Chateauvieux, Sébastien ^a   Gaigneaux, Anthoula ^a   Dicato, Mario ^a   Diederich, Marc ^b  

^a Kirchberg Hospital   (Luxembourg)

^b Seoul National University   (South Korea)

Author keywords

Differentiation; Erythropoiesis; Leukemia; lncRNA; Lymphoma; miRNA; ncRNA; Regulatory network; Transcription factors

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 106A; MICRORNA 142; MICRORNA 144; MICRORNA 146A; MICRORNA 155; MICRORNA 17 5P; MICRORNA 20A; MICRORNA 221; MICRORNA 222; MICRORNA 223; MICRORNA 27A; MICRORNA 451; SMALL UNTRANSLATED RNA; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

BINDING AFFINITY; CELL DIFFERENTIATION; ERYTHROPOIESIS; HEMATOPOIESIS; HUMAN; NONHUMAN; PROTEIN RNA BINDING; REGULATORY MECHANISM; REVIEW; RNA ANALYSIS; RNA PROCESSING; RNA STRUCTURE; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; GENE REGULATORY NETWORKS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MICRORNAS; RNA INTERFERENCE; RNA, UNTRANSLATED; TRANSCRIPTION FACTORS;

EID: 84880214797     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140714744     Document Type: Review

References (126)

1. Inaba, M.; Yamashita, Y.M. Asymmetric stem cell division: Precizsion for robustness. Cell Stem Cell 2012, 11, 461-469.
2. Lichtinger, M.; Ingram, R.; Hannah, R.; Muller, D.; Clarke, D.; Assi, S.A.; Lie, A.L.M.; Noailles, L.; Vijayabaskar, M.S.; Wu, M.; et al. RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis. EMBO J. 2012, 31, 4318-4333.
3. Papathanasiou, P.; Attema, J.L.; Karsunky, H.; Hosen, N.; Sontani, Y.; Hoyne, G.F.; Tunningley, R.; Smale, S.T.; Weissman, I.L. Self-renewal of the long-term reconstituting subset of hematopoietic stem cells is regulated by Ikaros. Stem Cells 2009, 27, 3082-3092.
4. Malinge, S.; Thiollier, C.; Chlon, T.M.; Dore, L.C.; Diebold, L.; Bluteau, O.; Mabialah, V.; Vainchenker, W.; Dessen, P.; Winandy, S.; et al. Ikaros inhibits megakaryopoiesis through functional interaction with GATA-1 and NOTCH signaling. Blood 2013, 121, 2440-2451.
5. Mattick, J.S. Non-coding RNAs: The architects of eukaryotic complexity. EMBO Reports 2001, 2, 986-991.
6. Mattick, J.S.; Makunin, I.V. Non-coding RNA. Hum. Mol. Gen. 2006, 15, R17-R29.
7. Pheasant, M.; Mattick, J.S. Raising the estimate of functional human sequences. Genome Res. 2007, 17, 1245-1253.
8. Fire, A.; Xu, S.; Montgomery, M.K.; Kostas, S.A.; Driver, S.E.; Mello, C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391, 806-811.
9. Wightman, B.; Ha, I.; Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75, 855-862.
10. Hamilton, A.J.; Baulcombe, D.C. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999, 286, 950-952.
11. Elbashir, S.M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411, 494-498.
12. Huang, X.; Yuan, T.; Tschannen, M.; Sun, Z.; Jacob, H.; Du, M.; Liang, M.; Dittmar, R.L.; Liu, Y.; Liang, M.; et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics 2013, 14, 319.
13. Lee, R.C.; Feinbaum, R.L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75, 843-854.
14. Lau, N.C.; Lim, L.P.; Weinstein, E.G.; Bartel, D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294, 858-862.
15. Lagos-Quintana, M.; Rauhut, R.; Lendeckel, W.; Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294, 853-858.
16. Lee, R.C.; Ambros, V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294, 862-864.
17. Pillai, R.S.; Bhattacharyya, S.N.; Artus, C.G.; Zoller, T.; Cougot, N.; Basyuk, E.; Bertrand, E.; Filipowicz, W. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 2005, 309, 1573-1576.
18. Friedman, R.C.; Farh, K.K.; Burge, C.B.; Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19, 92-105.
19. Lewis, B.P.; Shih, I.H.; Jones-Rhoades, M.W.; Bartel, D.P.; Burge, C.B. Prediction of mammalian microRNA targets. Cell 2003, 115, 787-798.
20. Wang, Z.; Yao, H.; Lin, S.; Zhu, X.; Shen, Z.; Lu, G.; Poon, W.S.; Xie, D.; Lin, M.C.; Kung, H.F. Transcriptional and epigenetic regulation of human microRNAs. Cancer Lett. 2013, 331, 1-10.
21. Kloosterman, W.P.; Plasterk, R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 2006, 11, 441-450.
22. Yates, L.A.; Norbury, C.J.; Gilbert, R.J. The long and short of microRNA. Cell 2013, 153, 516-519.
23. Borchert, G.M.; Lanier, W.; Davidson, B.L. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 2006, 13, 1097-1101.
24. Altuvia, Y.; Landgraf, P.; Lithwick, G.; Elefant, N.; Pfeffer, S.; Aravin, A.; Brownstein, M.J.; Tuschl, T.; Margalit, H. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 2005, 33, 2697-2706.
25. Guo, H.; Ingolia, N.T.; Weissman, J.S.; Bartel, D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466, 835-840.
26. Wu, L.; Fan, J.; Belasco, J.G. MicroRNAs direct rapid deadenylation of mRNA. Proc. Natl. Acad. Sci. USA 2006, 103, 4034-4039.
27. Zardo, G.; Ciolfi, A.; Vian, L.; Starnes, L.M.; Billi, M.; Racanicchi, S.; Maresca, C.; Fazi, F.; Travaglini, L.; Noguera, N.; et al. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood 2012, 119, 4034-4046.
28. Johnnidis, J.B.; Harris, M.H.; Wheeler, R.T.; Stehling-Sun, S.; Lam, M.H.; Kirak, O.; Brummelkamp, T.R.; Fleming, M.D.; Camargo, F.D. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451, 1125-1129.
29. Fazi, F.; Rosa, A.; Fatica, A.; Gelmetti, V.; De Marchis, M.L.; Nervi, C.; Bozzoni, I. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005, 123, 819-831.
30. Fukao, T.; Fukuda, Y.; Kiga, K.; Sharif, J.; Hino, K.; Enomoto, Y.; Kawamura, A.; Nakamura, K.; Takeuchi, T.; Tanabe, M. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 2007, 129, 617-631.
31. Masaki, S.; Ohtsuka, R.; Abe, Y.; Muta, K.; Umemura, T. Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem. Biophys. Res. Commun. 2007, 364, 509-514.
32. Monticelli, S.; Ansel, K.M.; Xiao, C.; Socci, N.D.; Krichevsky, A.M.; Thai, T.H.; Rajewsky, N.; Marks, D.S.; Sander, C.; Rajewsky, K.; et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol. 2005, 6, R71.
33. Lu, J.; Getz, G.; Miska, E.A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B.L.; Mak, R.H.; Ferrando, A.A.; et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435, 834-838.
34. Choong, M.L.; Yang, H.H.; McNiece, I. MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp. Hematol. 2007, 35, 551-564.
35. Felli, N.; Pedini, F.; Romania, P.; Biffoni, M.; Morsilli, O.; Castelli, G.; Santoro, S.; Chicarella, S.; Sorrentino, A.; Peschle, C.; et al. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica 2009, 94, 479-486.
36. Cline, M.S.; Smoot, M.; Cerami, E.; Kuchinsky, A.; Landys, N.; Workman, C.; Christmas, R.; Avila-Campilo, I.; Creech, M.; Gross, B.; et al. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2007, 2, 2366-2382.
37. Zhou, K.; Yi, S.; Yu, Z.; Li, Z.; Wang, Y.; Zou, D.; Qi, J.; Zhao, Y.; Qiu, L. MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia. Leukemia Lymphoma 2012, 53, 1155-1161.
38. Chen, M.J.; Yokomizo, T.; Zeigler, B.M.; Dzierzak, E.; Speck, N.A. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009, 457, 887-891.
39. Okuda, T.; Takeda, K.; Fujita, Y.; Nishimura, M.; Yagyu, S.; Yoshida, M.; Akira, S.; Downing, J.R.; Abe, T. Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy. Mol. Cell. Biol. 2000, 20, 319-328.
40. Wang, Q.; Stacy, T.; Binder, M.; Marin-Padilla, M.; Sharpe, A.H.; Speck, N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 1996, 93, 3444-3449.
41. Yokomizo, T.; Ogawa, M.; Osato, M.; Kanno, T.; Yoshida, H.; Fujimoto, T.; Fraser, S.; Nishikawa, S.; Okada, H.; Satake, M.; et al. Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells. Genes Cells 2001, 6, 13-23.
42. Nishimura, M.; Fukushima-Nakase, Y.; Fujita, Y.; Nakao, M.; Toda, S.; Kitamura, N.; Abe, T.; Okuda, T. VWRPY motif-dependent and-independent roles of AML1/Runx1 transcription factor in murine hematopoietic development. Blood 2004, 103, 562-570.
43. Ran, D.; Shia, W.J.; Lo, M.C.; Fan, J.B.; Knorr, D.A.; Ferrell, P.I.; Ye, Z.; Yan, M.; Cheng, L.; Kaufman, D.S.; et al. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood 2013, 121, 2882-2890.
44. Fazi, F.; Racanicchi, S.; Zardo, G.; Starnes, L.M.; Mancini, M.; Travaglini, L.; Diverio, D.; Ammatuna, E.; Cimino, G.; Lo-Coco, F.; et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 2007, 12, 457-466.
45. Nimer, S.D.; Moore, M.A. Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells. Oncogene 2004, 23, 4249-4254.
46. Frank, R.; Zhang, J.; Uchida, H.; Meyers, S.; Hiebert, S.W.; Nimer, S.D. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 1995, 11, 2667-2674.
47. Zhang, D.E.; Fujioka, K.; Hetherington, C.J.; Shapiro, L.H.; Chen, H.M.; Look, A.T.; Tenen, D.G. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol. Cell. Biol. 1994, 14, 8085-8095.
48. Sun, W.; Shen, W.; Yang, S.; Hu, F.; Li, H.; Zhu, T.H. miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-beta. Cell Res. 2010, 20, 1158-1169.
49. Warren, A.J.; Colledge, W.H.; Carlton, M.B.; Evans, M.J.; Smith, A.J.; Rabbitts, T.H. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 1994, 78, 45-57.
50. Wadman, I.A.; Osada, H.; Grutz, G.G.; Agulnick, A.D.; Westphal, H.; Forster, A.; Rabbitts, T.H. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 1997, 16, 3145-3157.
51. Starnes, L.M.; Sorrentino, A.; Ferracin, M.; Negrini, M.; Pelosi, E.; Nervi, C.; Peschle, C. A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells. Leukemia 2010, 24, 1220-1223.
52. Starnes, L.M.; Sorrentino, A.; Pelosi, E.; Ballarino, M.; Morsilli, O.; Biffoni, M.; Santoro, S.; Felli, N.; Castelli, G.; de Marchis, M.L.; et al. NFI-A directs the fate of hematopoietic progenitors to the erythroid or granulocytic lineage and controls beta-globin and G-CSF receptor expression. Blood 2009, 114, 1753-1763.
53. Sun, Y.; Sun, J.; Tomomi, T.; Nieves, E.; Mathewson, N.; Tamaki, H.; Evers, R.; Reddy, P. PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6. J. Immunol. 2013, 190, 4005-4013.
54. Brioschi, M.; Fischer, J.; Cairoli, R.; Rossetti, S.; Pezzetti, L.; Nichelatti, M.; Turrini, M.; Corlazzoli, F.; Scarpati, B.; Morra, E.; et al. Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits. Neoplasia 2010, 12, 866-876.
55. Feng, J.; Iwama, A.; Satake, M.; Kohu, K. MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1. Br. J. Haematol. 2009, 145, 412-423.
56. Ben-Ami, O.; Pencovich, N.; Lotem, J.; Levanon, D.; Groner, Y. A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis. Proc. Natl. Acad. Sci. USA 2009, 106, 238-243.
57. Rossetti, S.; Sacchi, N. RUNX1: A microRNA hub in normal and malignant hematopoiesis. Int. J. Mol. Sci. 2013, 14, 1566-1588.
58. Wontakal, S.N.; Guo, X.; Will, B.; Shi, M.; Raha, D.; Mahajan, M.C.; Weissman, S.; Snyder, M.; Steidl, U.; Zheng, D.; et al. A large gene network in immature erythroid cells is controlled by the myeloid and B cell transcriptional regulator PU.1. PLoS Genet. 2011, 7, e1001392.
59. Houston, I.B.; Kamath, M.B.; Schweitzer, B.L.; Chlon, T.M.; DeKoter, R.P. Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality. Exp. Hematol. 2007, 35, 1056-1068.
60. Anderson, M.K.; Weiss, A.H.; Hernandez-Hoyos, G.; Dionne, C.J.; Rothenberg, E.V. Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity 2002, 16, 285-296.
61. Dionne, C.J.; Tse, K.Y.; Weiss, A.H.; Franco, C.B.; Wiest, D.L.; Anderson, M.K.; Rothenberg, E.V. Subversion of T lineage commitment by PU.1 in a clonal cell line system. Dev. Biol. 2005, 280, 448-466.
62. Laiosa, C.V.; Stadtfeld, M.; Xie, H.; de Andres-Aguayo, L.; Graf, T. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. Immunity 2006, 25, 731-744.
63. Lefebvre, J.M.; Haks, M.C.; Carleton, M.O.; Rhodes, M.; Sinnathamby, G.; Simon, M.C.; Eisenlohr, L.C.; Garrett-Sinha, L.A.; Wiest, D.L. Enforced expression of Spi-B reverses T lineage commitment and blocks beta-selection. J. Immunol. 2005, 174, 6184-6194.
64. Ghani, S.; Riemke, P.; Schonheit, J.; Lenze, D.; Stumm, J.; Hoogenkamp, M.; Lagendijk, A.; Heinz, S.; Bonifer, C.; Bakkers, J.; et al. Macrophage development from HSCs requires PU.1-coordinated microRNA expression. Blood 2011, 118, 2275-2284.
65. Rosa, A.; Ballarino, M.; Sorrentino, A.; Sthandier, O.; de Angelis, F.G.; Marchioni, M.; Masella, B.; Guarini, A.; Fatica, A.; Peschle, C.; et al. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. USA 2007, 104, 19849-19854.
66. Rhodes, J.; Hagen, A.; Hsu, K.; Deng, M.; Liu, T.X.; Look, A.T.; Kanki, J.P. Interplay of pu.1 and gata1 determines myelo-erythroid progenitor cell fate in zebrafish. Dev. Cell 2005, 8, 97-108.
67. Zhang, P.; Zhang, X.; Iwama, A.; Yu, C.; Smith, K.A.; Mueller, B.U.; Narravula, S.; Torbett, B.E.; Orkin, S.H.; Tenen, D.G. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 2000, 96, 2641-2648.
68. Stachura, D.L.; Chou, S.T.; Weiss, M.J. Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1. Blood 2006, 107, 87-97.
69. Chou, S.T.; Khandros, E.; Bailey, L.C.; Nichols, K.E.; Vakoc, C.R.; Yao, Y.; Huang, Z.; Crispino, J.D.; Hardison, R.C.; Blobel, G.A.; et al. Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate. Blood 2009, 114, 983-994.
70. Dore, L.C.; Amigo, J.D.; Dos Santos, C.O.; Zhang, Z.; Gai, X.; Tobias, J.W.; Yu, D.; Klein, A.M.; Dorman, C.; Wu, W.; et al. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc. Natl. Acad. Sci. USA 2008, 105, 3333-3338.
71. Papapetrou, E.P.; Korkola, J.E.; Sadelain, M. A genetic strategy for single and combinatorial analysis of miRNA function in mammalian hematopoietic stem cells. Stem Cells 2010, 28, 287-296.
72. Pase, L.; Layton, J.E.; Kloosterman, W.P.; Carradice, D.; Waterhouse, P.M.; Lieschke, G.J. miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2. Blood 2009, 113, 1794-1804.
73. Minegishi, N.; Suzuki, N.; Yokomizo, T.; Pan, X.; Fujimoto, T.; Takahashi, S.; Hara, T.; Miyajima, A.; Nishikawa, S.; Yamamoto, M. Expression and domain-specific function of GATA-2 during differentiation of the hematopoietic precursor cells in midgestation mouse embryos. Blood 2003, 102, 896-905.
74. Bruchova, H.; Yoon, D.; Agarwal, A.M.; Mendell, J.; Prchal, J.T. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp. Hematol. 2007, 35, 1657-1667.
75. Mizuno, Y.; Tokuzawa, Y.; Ninomiya, Y.; Yagi, K.; Yatsuka-Kanesaki, Y.; Suda, T.; Fukuda, T.; Katagiri, T.; Kondoh, Y.; Amemiya, T.; et al. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett. 2009, 583, 2263-2268.
76. Orom, U.A.; Derrien, T.; Beringer, M.; Gumireddy, K.; Gardini, A.; Bussotti, G.; Lai, F.; Zytnicki, M.; Notredame, C.; Huang, Q.; et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010, 143, 46-58.
77. Carninci, P.; Kasukawa, T.; Katayama, S.; Gough, J.; Frith, M.C.; Maeda, N.; Oyama, R.; Ravasi, T.; Lenhard, B.; Wells, C.; et al. The transcriptional landscape of the mammalian genome. Science 2005, 309, 1559-1563.
78. Carninci, P.; Hayashizaki, Y. Noncoding RNA transcription beyond annotated genes. Curr. Opin. Genetics Dev. 2007, 17, 139-144.
79. Gibb, E.A.; Vucic, E.A.; Enfield, K.S.; Stewart, G.L.; Lonergan, K.M.; Kennett, J.Y.; Becker-Santos, D.D.; MacAulay, C.E.; Lam, S.; Brown, C.J.; et al. Human cancer long non-coding RNA transcriptomes. PLoS One 2011, 6, e25915.
80. Whitehead, J.; Pandey, G.K.; Kanduri, C. Regulation of the mammalian epigenome by long noncoding RNAs. Biochim. Biophys. Acta 2009, 1790, 936-947.
81. Yoon, J.H.; Abdelmohsen, K.; Gorospe, M. Posttranscriptional gene regulation by long noncoding RNA. J. Mol. Biol. in press, 2012.
82. Tripathi, V.; Ellis, J.D.; Shen, Z.; Song, D.Y.; Pan, Q.; Watt, A.T.; Freier, S.M.; Bennett, C.F.; Sharma, A.; Bubulya, P.A.; et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 2010, 39, 925-938.
83. Moon, S.L.; Anderson, J.R.; Kumagai, Y.; Wilusz, C.J.; Akira, S.; Khromykh, A.A.; Wilusz, J. A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability. RNA 2012, 18, 2029-2040.
84. Faghihi, M.A.; Modarresi, F.; Khalil, A.M.; Wood, D.E.; Sahagan, B.G.; Morgan, T.E.; Finch, C.E.; St Laurent, G., 3rd; Kenny, P.J.; Wahlestedt, C. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat. Med. 2008, 14, 723-730.
85. Kim, Y.K.; Furic, L.; Parisien, M.; Major, F.; DesGroseillers, L.; Maquat, L.E. Staufen1 regulates diverse classes of mammalian transcripts. EMBO J. 2007, 26, 2670-2681.
86. Yoon, J.H.; Abdelmohsen, K.; Srikantan, S.; Yang, X.; Martindale, J.L.; De, S.; Huarte, M.; Zhan, M.; Becker, K.G.; Gorospe, M. LincRNA-p21 suppresses target mRNA translation. Mol. Cell 2012, 47, 648-655.
87. Carrieri, C.; Cimatti, L.; Biagioli, M.; Beugnet, A.; Zucchelli, S.; Fedele, S.; Pesce, E.; Ferrer, I.; Collavin, L.; Santoro, C.; et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 2012, 491, 454-457.
88. Kindler, S.; Wang, H.; Richter, D.; Tiedge, H. RNA transport and local control of translation. Annu. Rev. Cell Dev. Biol. 2005, 21, 223-245.
89. Clark, M.B.; Johnston, R.L.; Inostroza-Ponta, M.; Fox, A.H.; Fortini, E.; Moscato, P.; Dinger, M.E.; Mattick, J.S. Genome-wide analysis of long noncoding RNA stability. Genome Res. 2012, 22, 885-898.
90. Brown, J.A.; Valenstein, M.L.; Yario, T.A.; Tycowski, K.T.; Steitz, J.A. Formation of triple-helical structures by the 3'-end sequences of MALAT1 and MENbeta noncoding RNAs. Proc. Natl. Acad. Sci. USA 2012, 109, 19202-19207.
91. Wilusz, J.E.; Jnbaptiste, C.K.; Lu, L.Y.; Kuhn, C.D.; Joshua-Tor, L.; Sharp, P.A. A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails. Genes Dev. 2012, 26, 2392-2407.
92. Jalali, S.; Bhartiya, D.; Lalwani, M.K.; Sivasubbu, S.; Scaria, V. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One 2013, 8, e53823.
93. Hung, T.; Chang, H.Y. Long noncoding RNA in genome regulation: Prospects and mechanisms. RNA Biol. 2010, 7, 582-585.
94. Martianov, I.; Ramadass, A.; Serra Barros, A.; Chow, N.; Akoulitchev, A. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 2007, 445, 666-670.
95. Wang, K.C.; Chang, H.Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 2011, 43, 904-914.
96. Da Sacco, L.; Baldassarre, A.; Masotti, A. Bioinformatics tools and novel challenges in long non-coding RNAs (lncRNAs) functional analysis. Int. J. Mol. Sci. 2012, 13, 97-114.
97. Heo, J.B.; Sung, S. Vernalization-mediated epigenetic silencing by a long intronic noncoding RNA. Science 2011, 331, 76-79.
98. Swiezewski, S.; Liu, F.; Magusin, A.; Dean, C. Cold-induced silencing by long antisense transcripts of an Arabidopsis Polycomb target. Nature 2009, 462, 799-802.
99. Cesana, M.; Cacchiarelli, D.; Legnini, I.; Santini, T.; Sthandier, O.; Chinappi, M.; Tramontano, A.; Bozzoni, I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011, 147, 358-369.
100. Poliseno, L.; Salmena, L.; Riccardi, L.; Fornari, A.; Song, M.S.; Hobbs, R.M.; Sportoletti, P.; Varmeh, S.; Egia, A.; Fedele, G.; et al. Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci. Signal. 2010, 3, ra29.
101. Torarinsson, E.; Sawera, M.; Havgaard, J.H.; Fredholm, M.; Gorodkin, J. Thousands of corresponding human and mouse genomic regions unalignable in primary sequence contain common RNA structure. Genome Res. 2006, 16, 885-889.
102. Espinoza, C.A.; Allen, T.A.; Hieb, A.R.; Kugel, J.F.; Goodrich, J.A. B2 RNA binds directly to RNA polymerase II to repress transcript synthesis. Nat. Struct. Mol. Biol. 2004, 11, 822-829.
103. Mariner, P.D.; Walters, R.D.; Espinoza, C.A.; Drullinger, L.F.; Wagner, S.D.; Kugel, J.F.; Goodrich, J.A. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol. Cell 2008, 29, 499-509.
104. Hu, J.; Xu, T.; Zhu, T.; Lou, Q.; Wang, X.; Wu, Y.; Huang, R.; Liu, J.; Liu, H.; Yu, F.; et al. Monoclonal antibodies against accumulation-associated protein affect EPS biosynthesis and enhance bacterial accumulation of Staphylococcus epidermidis. PLoS One 2011, 6, e20918.
105. Paralkar, V.R.; Weiss, M.J. A new 'Linc' between noncoding RNAs and blood development. Genes Dev. 2011, 25, 2555-2558.
106. McGlinn, E.; Yekta, S.; Mansfield, J.H.; Soutschek, J.; Bartel, D.P.; Tabin, C.J. In ovo application of antagomiRs indicates a role for miR-196 in patterning the chick axial skeleton through Hox gene regulation. Proc. Natl. Acad. Sci. USA 2009, 106, 18610-18615.
107. Crooks, G.M.; Fuller, J.; Petersen, D.; Izadi, P.; Malik, P.; Pattengale, P.K.; Kohn, D.B.; Gasson, J.C. Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors. Blood 1999, 94, 519-528.
108. Moore, M.A.; Dorn, D.C.; Schuringa, J.J.; Chung, K.Y.; Morrone, G. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Exp. Hematol. 2007, 35, 105-116.
109. Wang, Q.; Huang, Z.; Xue, H.; Jin, C.; Ju, X.L.; Han, J.D.; Chen, Y.G. MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 2008, 111, 588-595.
110. Jeggari, A.; Marks, D.S.; Larsson, E. miRcode: A map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics 2012, 28, 2062-2063.
111. Goshen, R.; Rachmilewitz, J.; Schneider, T.; de-Groot, N.; Ariel, I.; Palti, Z.; Hochberg, A.A. The expression of the H-19 and IGF-2 genes during human embryogenesis and placental development. Mol. Reproduct. Dev. 1993, 34, 374-379.
112. Nunez, C.; Bashein, A.M.; Brunet, C.L.; Hoyland, J.A.; Freemont, A.J.; Buckle, A.M.; Murphy, C.; Cross, M.A.; Lucas, G.; Bostock, V.J.; et al. Expression of the imprinted tumour-suppressor gene H19 is tightly regulated during normal haematopoiesis and is reduced in haematopoietic precursors of patients with the myeloproliferative disease polycythaemia vera. J. Pathol. 2000, 190, 61-68.
113. Tessema, M.; Langer, F.; Bock, O.; Seltsam, A.; Metzig, K.; Hasemeier, B.; Kreipe, H.; Lehmann, U. Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern. Int. J. Oncol. 2005, 26, 499-507.
114. Lustig, O.; Ariel, I.; Ilan, J.; Lev-Lehman, E.; De-Groot, N.; Hochberg, A. Expression of the imprinted gene H19 in the human fetus. Mol. Reproduct. Dev. 1994, 38, 239-246.
115. Borensztein, M.; Monnier, P.; Court, F.; Louault, Y.; Ripoche, M.A.; Tiret, L.; Yao, Z.; Tapscott, S.J.; Forne, T.; Montarras, D.; et al. Myod and H19-Igf2 locus interactions are required for diaphragm formation in the mouse. Development 2013, 140, 1231-1239.
116. Luo, M.; Li, Z.; Wang, W.; Zeng, Y.; Liu, Z.; Qiu, J. Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J. 2013, 280, 1709-1716.
117. Wagner, L.A.; Christensen, C.J.; Dunn, D.M.; Spangrude, G.J.; Georgelas, A.; Kelley, L.; Esplin, M.S.; Weiss, R.B.; Gleich, G.J. EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression. Blood 2007, 109, 5191-5198.
118. Bertani, S.; Sauer, S.; Bolotin, E.; Sauer, F. The noncoding RNA Mistral activates Hoxa6 and Hoxa7 expression and stem cell differentiation by recruiting MLL1 to chromatin. Mol. Cell 2011, 43, 1040-1046.
119. Jacob, E.; Hod-Dvorai, R.; Ben-Mordechai, O.L.; Boyko, Y.; Avni, O. Dual function of polycomb group proteins in differentiated murine T helper (CD4+) cells. J. Mol. Signal. 2011, 6, 5.
120. Jo, S.; Lee, H.; Kim, S.; Hwang, E.M.; Park, J.Y.; Kang, S.S.; Chung, H. Inhibition of PCGF2 enhances granulocytic differentiation of acute promyelocytic leukemia cell line HL-60 via induction of HOXA7. Biochem. Biophys. Res. Commun. 2011, 416, 86-91.
121. Porcher, C.; Swat, W.; Rockwell, K.; Fujiwara, Y.; Alt, F.W.; Orkin, S.H. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 1996, 86, 47-57.
122. Zhang, X.; Lian, Z.; Padden, C.; Gerstein, M.B.; Rozowsky, J.; Snyder, M.; Gingeras, T.R.; Kapranov, P.; Weissman, S.M.; Newburger, P.E. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood 2009, 113, 2526-2534.
123. Zhao, H.; Zhang, X.; Frazao, J.B.; Condino-Neto, A.; Newburger, P.E. HOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cells. J. Cell. Biochem. 2013, doi:10.1002/jcb.24586.
124. Savarese, F.; Flahndorfer, K.; Jaenisch, R.; Busslinger, M.; Wutz, A. Hematopoietic precursor cells transiently reestablish permissiveness for X inactivation. Mol. Cell. Biol. 2006, 26, 7167-7177.
125. Ahn, J.H.; Lee, Y.; Jeon, C.; Lee, S.J.; Lee, B.H.; Choi, K.D.; Bae, Y.S. Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis. Blood 2002, 100, 1742-1754.
126. Lee, M.Y.; Kim, W.J.; Kang, Y.J.; Jung, Y.M.; Kang, Y.M.; Suk, K.; Park, J.E.; Choi, E.M.; Choi, B.K.; Kwon, B.S.; et al. Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis. J. Leukocyte Biol. 2006, 80, 922-928.